Effects of Plasmapheresis on Serum Lithium Levels in an ICU Patient with Bipolar Disorder: A Case Study.
Ther Drug Monit
; 46(3): 281-284, 2024 Jun 01.
Article
en En
| MEDLINE
| ID: mdl-38723114
ABSTRACT
ABSTRACT This is a case description of a patient with bipolar disorder undergoing lithium therapy who received plasmapheresis for neuromyelitis optica spectrum disorder. Plasmapheresis resulted in lower and subtherapeutic serum lithium levels. Using therapeutic drug monitoring, a dose escalation of 80% was necessary to maintain therapeutic serum lithium levels. This underscores the importance of individualized therapy through therapeutic drug monitoring.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Trastorno Bipolar
/
Neuromielitis Óptica
/
Plasmaféresis
/
Monitoreo de Drogas
Idioma:
En
Revista:
Ther Drug Monit
Año:
2024
Tipo del documento:
Article